Non-alcoholic Fatty Liver Diseases (NAFLD) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD Subjects
Condition: NAFLD Interventions: Dietary Supplement: Placebo; Dietary Supplement: 2 cap.LivPhcD/per day; Dietary Supplement: 4 cap.LivPhcD/per day; Dietary Supplement: 6 cap.LivPhcD/per day Sponsor: TCM Biotech International Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 5, 2023 Category: Research Source Type: clinical trials
